Research and Markets: DRG Insight: Rheumatoid Arthritis (G7)The Herald | HeraldOnline.comBiologics from other drug classes – the interleukin-6 inhibitor tocilizumab (Roche/Chugai's Actemra/RoActemra), the selective costimulation modulator abatacept…
HaaretzTeva halts tests of cancer drug biosimilarHaaretzDeveloping a biosimilar generic version of Rituxan (rituximab) is a key goal of the joint venture that Teva, the biggest generic drugmaker in the world, formed in January 2009 with the Swiss compa…
XconomyCelgene antes up $35M, snags buyout option on VentiRx cancer workFierceBiotechThe first will be a combination study with docetaxel for ovarian cancer with the second–a combination with rituximab–aimed at head and neck cancer. For VentiRx the d…
The booming business in biosimilarsBusiness StandardThe current biosimilars portfolio of Dr Reddy's Laboratories constitutes of filgrastim, peg-filgrastim, rituximab and darbepeotin alfa, which have commercial presence in 13 emerging countries. “…
Watch-and-wait OK in low-tumor burden follicular lymphomaMedical XpressAn initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure or overall survival rate in selected patients with low-tumor burden folli…
Watch & Wait OK in Low-Tumor Burden Follicular LymphomaDoctors LoungeAn initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure or overall survival rate in selected patients with low-tumor burden fol…
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour …pharmabiz.comPatients had relapsed following a median of five prior therapies (range 2-15); 44% had failed prior stem cell transplant and 52% were rituximab refractory….
Drugs and dollarsNews & ObserverDuke University Health System charged $32,370 for rituximab, which treats lymphoma and leukemia. Duke settled for $19,420. Medicare would have allowed $6,420. Duke received $10,670 for a dose of Neulasta, which fights in…
Cancer drug mark-ups bring in big money for NC nonprofit hospitalsKansas City StarCarolinas Medical Center-NorthEast in Concord was paid about $19,000 for a one-gram dose of rituximab, used to treat lymphoma and leukemia. That was roughly three times t…
Spectrum Pharmaceuticals Provides Update on Belinostat Registrational Trial …MarketWatch (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on t…